The AVMXY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AVMXY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The AVMXY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View AVMXY Detailed Price Forecast - CNN Money||View AVMXY Detailed Summary - Google Finance|
|View AVMXY Detailed Summary - Yahoo! Finance||View AVMXY Stock Research & Analysis - Zacks.com|
|View AVMXY Trends & Analysis - Trade-Ideas||View AVMXY Major Holders - Barrons|
|View AVMXY Call Transcripts - NASDAQ||View AVMXY Breaking News & Analysis - Seeking Alpha|
|View AVMXY Annual Report - CompanySpotlight.com||View AVMXY OTC Short Report - OTCShortReport.com|
|View AVMXY Fundamentals - TradeKing||View AVMXY SEC Filings - Bar Chart|
|View Historical Prices for AVMXY - The WSJ||View Performance/Total Return for AVMXY - Morningstar|
|View the Analyst Estimates for AVMXY - MarketWatch||View the Earnings History for AVMXY - CNBC|
|View the AVMXY Earnings - StockMarketWatch||View AVMXY Buy or Sell Recommendations - MacroAxis|
|View the AVMXY Bullish Patterns - American Bulls||View AVMXY Short Pain Metrics - ShortPainBot.com|
|View AVMXY Stock Mentions - StockTwits||View AVMXY Stock Mentions - PennyStockTweets|
|View AVMXY Stock Mentions - Twitter||View AVMXY Investment Forum News - Investor Hub|
|View AVMXY Stock Mentions - Yahoo! Message Board||View AVMXY Stock Mentions - Seeking Alpha|
|View Insider Transactions for AVMXY - SECform4.com||View Insider Transactions for AVMXY - Insider Cow|
|View AVMXY Major Holdings Summary - CNBC||View Insider Disclosure for AVMXY - OTC Markets|
|View Insider Transactions for AVMXY - Yahoo! Finance||View Institutional Holdings for AVMXY - NASDAQ|
|View AVMXY Stock Insight & Charts - FinViz.com||View AVMXY Investment Charts - StockCharts.com|
|View AVMXY Stock Overview & Charts - BarChart||View AVMXY User Generated Charts - Trading View|
AVITA Medical Announces Institutional Placement of A$16.0 Million to Support U.S. Commercialization of the RECELL® Device
Posted on Tuesday June 05, 2018
AVITA Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds, and aesthetics indications, today announced an institutional placement of A$16.0 million to prepare for the planned U.S. launch of the RECELL® Device in the treatment of severe burns. Avita has received commitments from international and Australian institutional and sophisticated investors for a placement of A$16.0 million at an issue price of A$0.050 per share, with the placement to occur in two tranches.
AVITA Medical Announces Presentation at ISPOR Meeting Validating Acute Burn Health Economic Model
Posted on Monday May 21, 2018
AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced that results from a study validating the predicted outcomes and costs from an acute burns health economic model were presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting in Baltimore, Maryland. The landmark model is the first validated economic model available to assess the costs and clinical impact of new interventions versus standard of care for inpatient treatment of acute burns along the burn care continuum. The model demonstrates the ability to predict the cost-effectiveness, incremental costs and the budget impact of different care management approaches.
AVITA Medical today announced that its pivotal, controlled clinical trial in the treatment of deep full-thickness burns with the RECELL® Autologous Cell Harvesting Device achieved its co-primary endpoints, demonstrating a statistically significant reduction in donor skin requirements versus standard of care while achieving comparable definitive wound closure.
RECELL® Study in Facial Burns Shows Excellent Cosmetic Outcomes
Posted on Thursday April 12, 2018
AVITA Medical announced today results from a clinical study highlighting the potential benefits of the RECELL® Autologous Cell Harvesting Device in the treatment of deep partial-thickness facial burns.